Mary Namugosa
Papers
1
Total Citations
3
H-Index
1
About
Mary Namugosa is a urologic surgeon and researcher whose work centers on optimizing surgical approaches for upper tract urothelial carcinoma (UTUC), with a particular focus on comparing outcomes across open, laparoscopic, and robotic radical nephroureterectomy. Her most-cited study, published in 2025, systematically evaluates the surgical outcomes and costs of these three techniques, while also introducing the "tetrafecta" as a novel composite outcome measure—a significant contribution that aims to provide a more holistic assessment of surgical success beyond traditional metrics. This work has already garnered 3 citations in its early publication period, reflecting its timely relevance in the field. Namugosa’s research directly addresses the pressing need for evidence-based comparisons in minimally invasive surgery, helping to guide clinical decision-making for patients with UTUC. Her dedication to refining surgical standards and improving patient outcomes marks her as an emerging leader in urologic oncology, with her findings poised to influence both practice and future research in the management of upper tract cancers.
Research Focus
Key Achievements
Top Papers
- 1